TCR-mimicking STAR conveys superior sensitivity over CAR in targeting tumors with low-density neoantigens
Cell Reports · 2024-11 · 43 (11) · 114949
DOI: 10.1016/j.celrep.2024.114949 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-11. Verfasst von Daosheng Huang und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Tsinghua University, Beijing 100084, China; Institute for Immunology, Tsinghua University, Beijing 100084, China. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Antigens, Neoplasm, Receptors, Antigen, T-Cell. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Tsinghua University, Center for Life Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Targeting tumor-specific neoantigens holds promise for cancer immunotherapy, but their ultra-low expression on tumor cells poses challenges for T cell therapies. Here, we found that chimeric antigen receptors (CARs) exhibit 10-100 times lower sensitivity than T cell receptors (TCRs) when targeting human leukocyte antigen (HLA) class I-presented p53R175H neoantigen. To enhance CAR functionality, we introduced T cell receptor fusion constructs (TRuCs) and synthetic TCRs and antigen receptors (STARs). Our data show that STARs optimally reproduce TCR antigen sensitivity, outperforming CARs and TRuCs in redirecting CD8+ and CD4+ T cells to recognize HLA class I neoantigens. STAR-T cells demonstrate superior killing of cancer cell lines with low neoantigen density in vitro and improved tumor control in mouse models compared to CAR-T and TRuC-T cells. These findings highlight CAR sensitivity limitations and present STARs as more effective synthetic receptors for T cell-based immunotherapy against tumors with low neoantigen density.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Tsinghua University, Beijing 100084, China; Institute for Immunology, Tsinghua University, Beijing 100084, China.
- School of Basic Medical Sciences, Tsinghua University, Beijing 100084, China.
- School of Basic Medical Sciences, Tsinghua University, Beijing 100084, China; Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing 100084, China.
- School of Basic Medical Sciences, Tsinghua University, Beijing 100084, China; Institute for Immunology, Tsinghua University, Beijing 100084, China; Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing…
- Changping Laboratory, Beijing 102206, China.
Förderung
- Tsinghua University
- Center for Life Sciences
- National Natural Science Foundation of China
Zitieren
APA
Huang, D., Li, Y., Rui, W., Sun, K., Zhou, Z., Lv, X., Yu, L., Chen, J., Zhou, J., Liu, V., Wang, J., Lan, X., Fu, Y. X., Zhao, X., & Lin, X. (2024). TCR-mimicking STAR conveys superior sensitivity over CAR in targeting tumors with low-density neoantigens. Cell Reports, 43(11), 114949. https://doi.org/10.1016/j.celrep.2024.114949
Vancouver
Huang D, Li Y, Rui W, Sun K, Zhou Z, Lv X, et al. TCR-mimicking STAR conveys superior sensitivity over CAR in targeting tumors with low-density neoantigens. Cell Reports. 2024;43(11):114949. doi:10.1016/j.celrep.2024.114949
BibTeX
@article{Huang2024,
author = {Huang, Daosheng and Li, Yi and Rui, Wei and Sun, Keyong and Zhou, Zhixiao and Lv, Xiachen and Yu, Li and Chen, Junfan and Zhou, Jing and Liu, Vincent and Wang, Jiasheng and Lan, Xun and Fu, Yang-Xin and Zhao, Xueqiang and Lin, Xin},
title = {TCR-mimicking STAR conveys superior sensitivity over CAR in targeting tumors with low-density neoantigens},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {11},
pages = {114949},
doi = {10.1016/j.celrep.2024.114949}
}
EUVIMED